ArticleAnnals of hematology2026

Superior response and survival of intensive chemotherapy over venetoclax plus azacitidine in newly diagnosed KIT-mutated acute myeloid leukemia.

Qingli Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.